Css Llc/Il
Source: SEC Form 13F · as of Mar 2026Css Llc/Il holds 14 biotech & pharma companies tracked by BioSniper, totaling $14.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$14.6M
BioSniper AIPage evidence connected
Prepared research question
What matters most for IONIS PHARMACEUTICALS INC (IONS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| IONSIONIS PHARMACEUTICALS INC | 79,093 | $5.9M |
| APLSApellis Pharmaceuticals, Inc. | 42,818 | $1.7M |
| INCYIncyte Corp. | 12,068 | $1.1M |
| REGNREGENERON PHARMACEUTICALS, INC. | 1,170 | $904K |
| BMRNBIOMARIN PHARMACEUTICAL INC | 15,980 | $903K |
| TEVATeva Pharmaceutical Industries Limited | 27,070 | $815K |
| EXELEXELIXIS, INC. | 15,879 | $681K |
| CNTACentessa Pharmaceuticals plc | 17,000 | $675K |
| DAWNDay One Biopharmaceuticals, Inc. | 24,000 | $515K |
| FOLDAMICUS THERAPEUTICS, INC. | 33,500 | $484K |
| LSTALISATA THERAPEUTICS, INC. | 61,898 | $310K |
| OGNOrganon & Co. | 45,433 | $272K |
| TVTXTravere Therapeutics, Inc. | 7,470 | $222K |
| EVOEvotec SE | 12,100 | $30K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.